RE:Global cannabis pharmaceutical outlookThose reports can be very expensive and the only way those growth numbers gain credibility is if the projections are sourced from global pharmaceutical companies that intended to commercialize cannabis based pharmaceuticals. And having written that within this forum, I can only say, we are in a very, very, sweet spot with LABS stock.
Nicely done alleyesonme and let the trend be your friend, in this case, global trend.